+977 01-5009233/ 9863393960



Get Polio Vaccines for Kids in Kathmandu Nepal.

Do you need to get Polio vaccine for your children in Kathmandu Nepal?

Clinic One offers this vaccine in a clean and comfortable environment at a time that is convenient for you. We are open 7 days a week.  


IMOVAX POLIO is presented in the form of a suspension for injection (0.5ml) in a prefilled syringe with an attached needle or with two separate needles box of 1 or 20.

Indicated for infants, children and adults for the prevention of poliomyelitis. For primary vaccination and as a booster.



Primary Vaccination:

  • From 2 months of age, 3 successive injections of 0.5mI should he administered at intervals of one or two months.
  • From 6 weeks of age, IMOVAX POLIO may be administered following the 6, 10, 14 week schedule. As per the recommendations of the Expanded Programme on immunization of World Health Organization.
  • For non-vaccinated adults. 2 successive injections of 0.5ml must be given at intervals of one or
  • Preferably 2 months.


In children, in the second year of life, a 4th dose (1st booster) is administered one  year after the 3rd injection.

For adults, a 3 dose (1st booster) is administered 8 to 12 months after the 2 injection.

A booster is given every 5 years in children and adolescents and ever 1 years in adults.


The preferred route of administration is intramuscular, through the vaccine may also be given subcutaneously

The preferred site of intramuscular injection is the mid lateral aspects of’ the thigh in infants and toddlers and the deltoid muscle in children, adolescents and adults.


Do not use IMOVAX POLIO if you or your child:

  • Are allergic to active substances, to one of the excipients, to neomycin, to streptomycin or to polymyxine B or have had an allergic reaction following a previous injection of this vaccine
  • Have a fever of acute illness, in this case vaccination should be postponed.

Take special care with IMOVAX POLIO if you or our child:

  • Have thrombocytopenia (insufficient blood platelets, which play an important role in coagulation) or a bleeding disorder, because of the bleeding that can occur during intramuscular administration of the vaccine.
  • Are taking a treatment that suppresses your immune response or presenting with an immune deficiency disorder, in which case the immune response to vaccination may be reduced. In such cases it is recommended to postpone vaccination until the end of the treatment or to make sure the subjects is well protected. Vaccination of subjects with chronic immunodeficiency, such as HlV infection, is nevertheless recommended even if the immune response might be limited by the underlying illness.
  • This vaccine may also he indicated for subjects for whom the oral vaccine is contraindicated and is a booster for subjects previously vaccinated with the oral vaccine.
  • Do not inject by the intravascular route: make sure the needle does not penetrate a blood vessel.

Pregnancy and Breast feeding:

This vaccine may be used for pregnant women, if required. Breast feeding is not contraindicated.



The most frequently reported side effects are:

  • Local reactions at the injection site: pain, erythema (skin Redness)
  • Moderate fever

Other side effect, reported very rarely (<0.01%) are:

  • Edema
  • Lymphadenopathy (increase in the size of lymph nodes)
  • Hypersensitivity reaction (allergy): urtricaria, facial edema, anaphylactic shock in response to one of the vaccine components.
  • Joint pain, muscular pain
  • Convulsions (associated with fever), Headaches, tingling sensation
  • Agitation, somnolence and irritability in the first hours or days
  • Skin rash
  • In babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination

Additional Information at Center for Disease Control.